BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 29984337)

  • 1. Role of co-expression of estrogen receptor beta and Ki67 in prostate adenocarcinoma.
    Azizan N; Hayati F; Tizen NMS; Farouk WI; Masir N
    Investig Clin Urol; 2018 Jul; 59(4):232-237. PubMed ID: 29984337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of estrogen receptor β and Ki 67 in benign & malignant human prostate lesions by immunohistochemistry.
    Grover SK; Agarwal S; Gupta S; Wadhwa N; Sharma N
    Pathol Oncol Res; 2015 Jul; 21(3):651-7. PubMed ID: 25527409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low endoglin vascular density and Ki67 index in Gleason score 6 tumours may identify prostate cancer patients suitable for surveillance.
    Josefsson A; Wikström P; Egevad L; Granfors T; Karlberg L; Stattin P; Bergh A
    Scand J Urol Nephrol; 2012 Aug; 46(4):247-57. PubMed ID: 22452635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumour growth fraction measured by immunohistochemical staining of Ki67 is an independent prognostic factor in preoperative prostate biopsies with small-volume or low-grade prostate cancer.
    Zellweger T; Günther S; Zlobec I; Savic S; Sauter G; Moch H; Mattarelli G; Eichenberger T; Curschellas E; Rüfenacht H; Bachmann A; Gasser TC; Mihatsch MJ; Bubendorf L
    Int J Cancer; 2009 May; 124(9):2116-23. PubMed ID: 19117060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ki67 index in breast cancer: correlation with other prognostic markers and potential in pakistani patients.
    Haroon S; Hashmi AA; Khurshid A; Kanpurwala MA; Mujtuba S; Malik B; Faridi N
    Asian Pac J Cancer Prev; 2013; 14(7):4353-8. PubMed ID: 23992002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High immunoexpression of Ki67, EZH2, and SMYD3 in diagnostic prostate biopsies independently predicts outcome in patients with prostate cancer.
    Lobo J; Rodrigues Â; Antunes L; Graça I; Ramalho-Carvalho J; Vieira FQ; Martins AT; Oliveira J; Jerónimo C; Henrique R
    Urol Oncol; 2018 Apr; 36(4):161.e7-161.e17. PubMed ID: 29174711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunoexpression of estrogen receptor-β and progesterone receptor in prostate adenocarcinoma, does it inhibit neoplastic proliferation and invasion?
    Bera KN; Yadav SK; Prakash O; Singh S; Sarin N
    Indian J Pathol Microbiol; 2020 Feb; 63(Supplement):S30-S33. PubMed ID: 32108623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The expression and localization of estrogen receptor beta in hyperplastic and neoplastic prostate lesions.
    Levakov AF; Kaćanski MM; Vucković N; Zivojinov M; Amidzić J; Sabo JI
    Vojnosanit Pregl; 2015 Oct; 72(10):906-13. PubMed ID: 26665557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of geminin expression levels in Ki67-high subset of estrogen receptor-positive and HER2-negative breast cancers.
    Yagi T; Inoue N; Yanai A; Murase K; Imamura M; Miyagawa Y; Enomoto Y; Nishimukai A; Takatsuka Y; Hirota S; Akazawa K; Miyoshi Y
    Breast Cancer; 2016 Mar; 23(2):224-30. PubMed ID: 25082658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrogen receptor beta expression in prostate adenocarcinoma.
    Asgari M; Morakabati A
    Diagn Pathol; 2011 Jul; 6():61. PubMed ID: 21733187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of some selected cytokeratins and Ki67 protein in prostatic tumor: can these be used as tumor markers.
    Adisa JO; Egbujo EC; Ibrahim B; Musa B; Madukwe J
    Pan Afr Med J; 2015; 20():46. PubMed ID: 26090004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ki67 expression in breast cancer. Correlation with prognostic markers and clinicopathological parameters in Saudi patients.
    Elkablawy MA; Albasri AM; Mohammed RA; Hussainy AS; Nouh MM; Alhujaily AS
    Saudi Med J; 2016 Feb; 37(2):137-41. PubMed ID: 26837394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical expression of Ets-related gene-transcriptional factor in adenocarcinoma prostate and its correlation with Gleason score.
    Mannan R; Bhasin TS; Manjari M; Singh G; Bhatia PK; Sharma S
    Indian J Pathol Microbiol; 2016; 59(4):489-495. PubMed ID: 27721279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ki67 Frequency in Breast Cancers without Axillary Lymph Node Involvement and its Relation with Disease-free Survival.
    Shandiz FH; Shabahang H; Afzaljavan F; Sharifi N; Tavasoli A; Afzalaghaee M; Roshanzamir E; Pasdar A
    Asian Pac J Cancer Prev; 2016; 17(3):1347-50. PubMed ID: 27039770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Power of PgR expression as a prognostic factor for ER-positive/HER2-negative breast cancer patients at intermediate risk classified by the Ki67 labeling index.
    Kurozumi S; Matsumoto H; Hayashi Y; Tozuka K; Inoue K; Horiguchi J; Takeyoshi I; Oyama T; Kurosumi M
    BMC Cancer; 2017 May; 17(1):354. PubMed ID: 28532429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of estrogen receptor beta correlates with adverse prognosis in resected pancreatic adenocarcinoma.
    Seeliger H; Pozios I; Assmann G; Zhao Y; Müller MH; Knösel T; Kreis ME; Bruns CJ
    BMC Cancer; 2018 Oct; 18(1):1049. PubMed ID: 30373552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of pathologic complete response and Ki67 expression after neoadjuvant chemotherapy in breast cancer.
    Yoshioka T; Hosoda M; Yamamoto M; Taguchi K; Hatanaka KC; Takakuwa E; Hatanaka Y; Matsuno Y; Yamashita H
    Breast Cancer; 2015 Mar; 22(2):185-91. PubMed ID: 23645542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostate carcinoma expression of estrogen receptor-beta as detected by PPG5/10 antibody has positive association with primary Gleason grade and Gleason score.
    Torlakovic E; Lilleby W; Torlakovic G; Fosså SD; Chibbar R
    Hum Pathol; 2002 Jun; 33(6):646-51. PubMed ID: 12152165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ki-67 is a prognostic marker for hormone receptor positive tumors.
    Pérez-López ME; García-Gómez J; Alves MT; Paradela A; García-Mata J; García-Caballero T
    Clin Transl Oncol; 2016 Oct; 18(10):996-1002. PubMed ID: 26742937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival predictors in patients with prostate adenocarcinoma with hormonal blockade.
    Angulo JC; Redondo C; Sánchez-Chapado M; Colás B; Ropero S; López JI
    Pathol Res Pract; 2016 Oct; 212(10):899-903. PubMed ID: 27502465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.